(Press-News.org) Cancer metastasis is a major cause of cancer-related death. A research team at City University of Hong Kong (CityU) recently identified a protein that triggers the migration of liver and pancreatic cancer cells and metastasis, and is correlated with shortening the survival time of patients. The research findings were verified by in vitro and in vivo models, supported with clinical data, and are expected to provide a new potential target for cancer therapy.
“Cancer metastasis is a complex process. Stiffness in tumours and the surrounding tissues is known to increase along with the tumour growth, which creates confined spaces or channel-like tracks of pores for tumour cell migration and metastasis in multiple cancer types. But the mechanism of this confined migration remains unclear,” said Professor Michael Yang Mengsu, Vice-President (Research and Technology) and Yeung Kin Man Chair Professor of Biomedical Sciences at CityU, who led the cross-institutional research. “We aim to deeply study the cancer metastasis mechanism and identify novel genes and proteins related to it.”
Hepatocellular carcinoma (HCC) is the most common type of the second leading cause of cancer death worldwide – liver cancer. Pancreatic ductal adenocarcinoma (PDAC) is another highly aggressive cancer with a five-year survival rate of less than 10%. Both of them have a typical feature of solid tumours with excessive extracellular matrix (ECM) deposition containing confined pores or channel-like tracks that enable cancer cell migration. So the team chose these two different cancer types as the study subjects.
Developing methods to study the migration mechanism
In collaboration with the Second Affiliated Hospital of Chongqing Medical University (CQMU), Professor Yang’s team first collected HCC and PDAC specimens for analysis from 153 and 63 patients, respectively, who had not received chemotherapy or radiotherapy before surgery. The team also obtained human liver cancer and pancreatic cancer cell lines from the National Institutes of Health in the USA.
“The main challenge was to simulate the complex cancer microenvironment,” explained Professor Yang. “But there is a lack of study models for cell migration in confined environment. So we developed a series of multidimensional platforms and 2D and 3D in vitro and in vivo models to comprehensively study the cell migration process.”
These platforms and models include microfluidic chips for single-cell and collective cell migration, and hydrogels of various stiffness for 3D invasion assays to simulate the in vivo environment. The team also utilized next-generation sequencing (NGS) and liquid chromatography-mass spectrometry (LC-MS) to determine the differentially expressed genes and proteins in cancer tissues.
LH1 as a key factor in promoting confined migration of HCC and PDAC cells
Based on the transcriptomic analysis with NGS and proteomic analysis with LC-MS, the team identified a protein called lysyl hydroxylase 1 (LH1) as one of the most significantly overexpressed proteins in HCC tissues. The microfluidic chips and 3D invasion models they developed demonstrated LH1’s capability to promote confined migration at multidimensional levels, including speed and invasion capacity of HCC and PDAC cells. The effects can be suppressed by knocking down the expression of LH1.
They also demonstrated that LH1 could bind and stabilize Septin2 (SEPT2), a protein that plays an essential role in preparing the cells for high mechanical migration demand, to enhance the formation of an actin network. The actin network is the most dynamic element of the cytoskeleton, is distributed throughout the cell cytoplasm, and controls cell mechanics and motility. Thus, the enhanced formation of the actin network can promote the confined migration and metastasis of HCC and PDAC cells.
High LH1 expressed level results in poor prognosis for cancer patients
The research team also analysed the correlation between LH1 and prognosis (i.e. the development of disease and chance of relapse) of HCC and PDAC patients. The clinical samples showed that patients with higher LH1 expression, along with poor prognosis, had only half of the survival rate of the low LH1 expression group.
Moreover, HCC and PDAC patients with high LH1 expression experienced a shorter overall survival time from the date of diagnosis to death of 39 and 17 months, respectively, compared to 86 and 22 months for patients with a lower level of LH1. Also, their disease-free survival time from primary treatment to relapse of the disease was 11.5 and 14 months, respectively, compared to 41 and 19 months for patients with a lower LH1 level.
“The platforms and methods we developed provide a unique approach to study the confined migration of cancer cells,” said Professor Yang. “We demonstrated that LH1 promotes confined migration and metastasis of cancer cells by stabilising SEPT2, and that high LH1 is associated with poor prognosis of HCC and PDAC patients. The findings are expected to provide a potential new target for cancer diagnosis and drug development.”
The findings were published in the leading peer-reviewed cancer-related scientific journal Molecular Cancer, under the title “Lysyl hydroxylase LH1 promotes confined migration and metastasis of cancer cells by stabilizing Septin2 to enhance actin network”.
The first author is Ms Eileen Yang Zihan, a PhD student in Professor Yang’s research group. The corresponding authors are Professor Yang and Dr Zhou Zhihang, a former visiting scholar in Professor Yang’s group, and currently Associate Professor at the Second Affiliated Hospital of CQMU. The multi-institution team consists of researchers from the Department of Biomedical Sciences and the Tung Biomedical Sciences Centre at CityU, the Department of Gastroenterology and the Department of Pathology at the Second Affiliated Hospital of CQMU, the Precision Diagnostic and Therapeutic Technology Centre of CityU Futian Research Institute, and The Hong Kong Polytechnic University.
The research was supported by Hong Kong Research Grants Council, the National Natural Science Fund, and the Loop Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone Shenzhen Park Project.
https://www.cityu.edu.hk/research/stories/2023/03/09/cityu-researchers-identify-protein-promotes-cancer-metastasis-providing-new-potential-treatment-target
END
CityU researchers identify a protein that promotes cancer metastasis, providing a new potential treatment target
2023-03-09
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
An on-chip viscoelasticity sensor for biological fluids
2023-03-09
A research paper by scientists at the Hebei University of Technology and Shenzhen University developed an on-chip viscoelasticity sensor for biological fluids.
The new research paper, published on Jan. 10, 2023 in the journal Cyborg and Bionic Systems, reported a double-layered microfluidic sensor to detect the ultra-weak viscoelasticity in biological fluids.
“Most of human body fluids are non-Newtonian liquids, and the influence of viscoelasticity is often ignored for the sake of simplification of analysis. However, we ...
An overview of in vitro biological neural networks for robot intelligence
2023-03-09
A review paper by scientists at the Beijing Institute of Technology summarized recent efforts and future potentials in the use of in vitro biological neural networks (BNNs) for the realization of biological intelligence, with a focus on those related to robot intelligence.
The review paper, published on Jan. 10 in the journal Cyborg and Bionic Systems, provided an overview of 1) the underpinnings of intelligence presented in in vitro BNNs, such as memory and learning; 2) how these BNNs can be embodied with robots through bidirectional ...
ASBMB announces 2023 class of fellows
2023-03-09
The American Society for Biochemistry and Molecular Biology today announced its 2023 class of fellows. The honorific program recognizes scientists who have made outstanding contributions to the field through their research, teaching, mentoring or other forms of service.
The society will recognize the 20 new fellows at its annual meeting, Discover BMB, later this month in Seattle. The presentation will be part of the society's presidential address and business meeting scheduled for Saturday, March 25.
“This group truly represents members who have ...
Novel rare skin mutation gene identified by whole exome sequencing - BGI Case Report
2023-03-09
Harlequin ichthyosis (HI) is a severe genetic skin disorder characterized by thick white, brown, or dark brown patches on the skin covering a newborn's entire body. HI has a low incidence of 1 per 300,000 live births but comes with the highest mortality rate among skin conditions. It is caused by a mutation in the ABCA12 gene, which codes for a protein involved in transporting lipids necessary for the formation of the skin barrier. Such protein shortage leads to a weaker epidermal barrier.
A recent study, co-authored by BGI Genomics Dr. Thomas Qiu, published in Frontiers in Pediatrics covers ...
Like a flexible Lego railway track: How stable microtubules form within cells
2023-03-09
Like poles support a tent, microtubules—hollow cylindrical structures made of tubulin protein—support eukaryotic cells. But microtubules provide more than just mechanical strength; they help prepare the cell for cell division and migration and work as a railway track on which motor proteins transport materials within the cell. The formation of microtubules within cells resembles how a child assembles a Lego train track. The tubulins—Lego bricks—constantly assemble and disassemble to make the microtubule—train track—longer and shorter in processes called polymerization and depolymerization. The processes are regulated by microtubule-associated proteins such ...
What if California didn’t close down during the pandemic?
2023-03-09
SAN FRANCISCO (March 9, 2023) — Researchers at the California Academy of Sciences, along with a collaborator at Denison University, have developed an innovative new model to assess how the California economy might have fared without economic closures to slow the spread of the coronavirus pandemic. Their initial findings—published today in Frontiers in Physics—reveal that under a “business-as-usual” approach wherein there were no business closures, California’s economy would have generally been better off than in reality. However, the economic impacts would still have been substantial and ...
Americans share fake news to fit in with social circles
2023-03-09
Both conservative and liberal Americans share fake news because they don’t want to be ostracized from their social circles, according to research published by the American Psychological Association.
“Conformity and social pressure are key motivators of the spread of fake news,” said lead researcher Matthew Asher Lawson, PhD, an assistant professor of decision sciences at INSEAD, a business school in France. “If someone in your online tribe is sharing fake news, then you feel pressure to share it as well, even if you don’t ...
A safe synthesis of hydrogen peroxide inspired by nature
2023-03-09
Fukuoka, Japan—Hydrogen peroxide is a ubiquitous chemical found in most homes and used in everything from dying hair to treating wounds. It is also an invaluable agent for many industries from food, textiles, and even in semiconductor production.
Reporting in JACS, researchers at Kyushu University have developed a new process to synthesize this chemical utilizing a new homogeneous catalyst inspired by nature. Moreover, the process is significantly safer than conventional methods.
Scientists have been reporting the synthesis ...
A novel mechanism may be effective in patients with severe hypertriglyceridemia and prior episodes of acute pancreatitis
2023-03-09
A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of acute pancreatitis. sHTG is a well-established risk factor for recurrent episodes of acute pancreatitis. These high-risk patients were the focus of a phase 2 study that was led by the Icahn School of Medicine at Mount Sinai and sponsored and funded by Regeneron.
This ANGPTL3 inhibitor therapy, the intravenous drug evicanumab-dgnb, inhibits two important regulators of lipoprotein metabolism. ...
Researchers unveil smart contact lens, capable of implementing AR-based navigation
2023-03-09
With the advent of the Metaverse era, there have been growing expectations that virtual reality (VR) and augmented reality (AR) technologies will likely to enhance convenience in everyday life, as well as industry productivity performance.
A joint research team, affiliated with UNIST has introduced core technology for smart contact lenses that can implement AR-based navigation through a 3D printing process. According to the research team, the new smart contact lenses can be worn inside the eye of a person, like a normal contact lens.
Published in the February 2023 issue of Advanced Science, this breakthrough has been jointly led by ...